针对COVID-19呼吸衰竭的V-V ECMO转诊者的选
Erin Niles1, Daniel J Haase2,3,4, Quincy Tran2,4
1Critical Care Resuscitation Unit, R Adams Cowley Shock Trauma Center, Baltimore, Maryland, USA.
Artificial organs
|March 29, 2024
概括
高气道压力释放通风 (APRV) 设置和年轻年龄预测接受COVID-19患者体外膜氧化 (ECMO) 评估. 这种分拣过程促进了转移,大多数被接受的患者获得了ECMO支持.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 随着COVID-19的流行,对于严重的急性呼吸困扰综合征,需要增加对体外膜氧化 (ECMO) 的使用.
- 有效的患者分组和转移协议到专门的ECMO中心成为优化结果的关键.
研究的目的:
- 为了确定患者转移用于静脉静脉ECMO (V-V ECMO) 评估的预测因素.
- 描述接受V-V ECMO转移的患者的结果.
主要方法:
- 一个单一中心,对V-V ECMO转移请求的回顾性分析,用于呼吸衰竭的成年COVID-19患者.
- 在2020年3月至2021年3月的临床分拣过程中,从前性地收集数据.
主要成果:
- 在341名转诊患者中,112名 (33%) 被接受转诊,229名 (67%) 被拒绝转诊.
- 高气道压力释放通风 (APRV) 压力和年轻年龄与接受转移有显著的关联.
- 接受治疗的患者心脏/功能障碍较少,机械通风持续时间较短.
结论:
- 建立的分拣过程成功地确定了适合V-V ECMO的候选人,转移了三分之一的转诊患者.
- 近70%的转移患者最终获得了ECMO支持.
- 高APRV设置和年轻年龄预测转移接受;需要对未转移患者进行进一步研究.
相关概念视频
Acute Respiratory Failure-V
137
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
137
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Acute Respiratory Failure-II
222
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
222
Acute Respiratory Failure-I
204
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
204
Acute Respiratory Failure-IV
154
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
154
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
206
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
206


